Product image of Liprolog (Insulin Lispro) supplied by GNH India

Liprolog

Active Ingredient:
Insulin Lispro
Origin:
EU

Liprolog (Insulin Lispro)

Insulin Lispro, the active ingredient in Liprolog, is a fast‑acting insulin analog presented as an injectable solution for subcutaneous and intravenous use. It is used to lower blood glucose levels in patients with diabetes mellitus, providing rapid post‑prandial control.
GNH India supplies Liprolog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Eli Lilly Nederland B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Liprolog (Insulin Lispro) is a rapid‑acting insulin analog used in the management of diabetes mellitus and related glucose‑control strategies.

  • Type 1 diabetes mellitus: provides rapid post‑prandial glucose reduction.
  • Type 2 diabetes mellitus: helps control mealtime glucose excursions.
  • Insulin pump therapy: serves as a fast‑acting bolus insulin for continuous subcutaneous insulin infusion devices.

How It Works

  • Insulin Lispro binds to insulin receptors on muscle and adipose cells, activating the receptor’s tyrosine kinase activity. This triggers intracellular signaling cascades that promote translocation of GLUT‑4 transporters to the cell membrane, enhancing glucose uptake. Simultaneously, hepatic glucose production is suppressed, resulting in a rapid decline of circulating blood glucose levels.

Side Effects

Common Side Effects

  • Hypoglycemia: low blood glucose episodes, especially if meals are missed.
  • Injection site reactions: redness, swelling, or itching at the injection site.
  • Weight gain: modest increase due to improved glucose utilization.
  • Lipodystrophy: localized changes in subcutaneous fat with repeated injections.
  • Localized allergic reactions: mild rash or urticaria at the site.

Serious or Rare Side Effects

  • Severe hypoglycemia: neurological impairment requiring immediate assistance.
  • Anaphylaxis: systemic allergic reaction with airway compromise.
  • Hypokalemia: low serum potassium levels, particularly with high doses.
  • Edema: peripheral swelling due to fluid retention.
  • Serum insulin antibodies: may alter insulin action.
  • Urticaria or angioedema: widespread hives or swelling.

Precautions & Warnings

When using Liprolog, consider the following precautions:

  • Dose adjustment: tailor insulin dose based on frequent blood glucose monitoring.
  • Hypoglycemia risk: educate patients on recognizing and treating low glucose episodes.
  • Renal impairment: monitor renal function and adjust dose as needed.
  • Hepatic impairment: use with caution and observe for altered glucose control.
  • Pregnancy and lactation: only use if benefits outweigh potential risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Liprolog may interact with several medications; awareness of these interactions helps maintain safe glucose control.

Major Interactions (Avoid)

  • Concurrent insulin products: risk of additive hypoglycemia.
  • Sulfonylureas or meglitinides: may cause severe hypoglycemia when combined.
  • Beta‑blockers: can mask hypoglycemia symptoms.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may potentiate insulin’s glucose‑lowering effect.
  • Thiazide diuretics: can increase blood glucose, requiring dose adjustments.
  • Systemic corticosteroids: raise glucose levels, potentially necessitating higher insulin doses.

Frequently Asked Questions

Liprolog contains insulin lispro, a rapid‑acting insulin analog used to control blood glucose levels in adults and children with type 1 or type 2 diabetes mellitus, particularly for mealtime and correction dosing.

Insulin lispro binds to insulin receptors on muscle and fat cells, quickly activating signaling pathways that move glucose transporters to the cell surface, thereby increasing glucose uptake and reducing hepatic glucose output.

The dose of Liprolog is individualized. A qualified prescriber determines the amount and timing based on the patient’s blood glucose readings, carbohydrate intake, and overall treatment plan.

Safety data are limited. Liprolog should only be used during pregnancy or lactation if the prescribing clinician judges that the potential benefits outweigh any possible risks to the mother or infant.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where needed) and import documentation.

Liprolog (insulin lispro) has a faster onset and shorter duration than regular human insulin, similar to other rapid‑acting analogs such as insulin aspart and insulin glulisine. Choice among them often depends on clinician preference, patient response, and formulary considerations.

Store Liprolog vials or cartridges at 2‑8 °C (refrigerated). Protect from light, do not freeze, and avoid shaking. Once in use, follow the manufacturer’s guidance on in‑use stability, typically keeping the vial at room temperature for a limited period.

Liprolog is given by subcutaneous injection into the abdomen, thigh, or upper arm, or intravenously in a clinical setting. The injection technique follows standard insulin administration practices, using appropriate needles or pen devices.

The most serious risks include severe hypoglycemia, which can cause loss of consciousness or seizures, and rare allergic reactions such as anaphylaxis. Prompt recognition and treatment are essential.

Liprolog is contraindicated in individuals with a known hypersensitivity to insulin lispro or any excipients in the formulation. Patients with severe hypoglycemia unawareness should use it only under close medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Insulin Lispro

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT